Proteus Digital Health developed digital medicines including ingestible sensors embedded in pharmaceutical tablets and wearable patches that detect medication adherence and monitor physiological response. The company pioneered sensor-enabled drug delivery technology combined with cloud-based data analytics for patient monitoring.
Proteus Digital Health has been acquired
This company is no longer available on our private secondary market.
Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Founded
2003
Total Funding
$322.5M
11 rounds
Latest Valuation
$1.5B
Apr 15, 2016
Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.
Total raised $322.5M across 11 rounds
Last updated 10-01-2026
| Date | Round | Amount Raised | Valuation | Lead Investors |
|---|---|---|---|---|
| Oct 11, 2018 | Strategic - Otsuka Pharmaceutical | $88M | — | Otsuka Pharmaceutical |
| Apr 15, 2016 | Series H Press release | $50M | $1.5B | Not disclosed |
| Jul 29, 2014 | Series G (second close) Press release | $52M | — | Not disclosed |
Andrew Thompson
Co-Founder; Chief Executive Officer until February 2020
Lawrence Perkins
Interim Chief Executive Officer (appointed February 2020)
George Savage
Co-Founder
Mark Zdeblick
Co-Founder
Competitor list is illustrative and may be incomplete, stale, or erroneous.
Medication Adherence Technologies
Companies offering digital health and adherence monitoring solutions
Access live market data
Sign UpData collected with AI, which can make mistakes. Please double-check this information.